Given that each APOE isoform has been shown to confer differential susceptibility to diseases, especially to AD, one possible explanation for the weaker age-related effects in our carriers group is the APOE4+ participants seem to be healthier than the APOE4− group. Here, APOE is linked to Alzheimer disease.